Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
Clinical trial NCT03496519 · WITHDRAWN
Trial details
- NCT number
- NCT03496519
- Sponsor
- University of Colorado, Denver
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2021-10-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.